相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Inositol-Triphosphate 3-Kinase C and DNA Methylation Involvement in NLRP3 Inflammasome Activation in Kawasaki Disease
Meng-Lei Ji et al.
INDIAN JOURNAL OF PEDIATRICS (2023)
Role of Inflammasomes in Kawasaki Disease COMMENT
Anju Gupta
INDIAN JOURNAL OF PEDIATRICS (2023)
Therapeutic Window of Intravenous Immunoglobulin (IVIG) and its correlation with IVIG-resistant in Kawasaki Disease: a retrospective study
Jiang Hui Cai et al.
JORNAL DE PEDIATRIA (2023)
Intravenous Immunoglobulin Therapy Restores the Quantity and Phenotype of Circulating Dendritic Cells and CD4+ T Cells in Children With Acute Kawasaki Disease
Nana Wang et al.
FRONTIERS IN IMMUNOLOGY (2022)
Stratified therapy for Kawasaki disease using a new scoring system to predict the response to a lower dose of intravenous immunoglobulin therapy
Misa Matsuura et al.
CARDIOLOGY IN THE YOUNG (2022)
Low- versus high-concentration intravenous immunoglobulin for children with Kawasaki disease in the acute phase
Takanori Suzuki et al.
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (2022)
High-Concentration Intravenous Immunoglobulin May Influence the Course of Fever and Rate of Reported Treatment Resistance in Children With Kawasaki Disease: A Single-Center Retrospective Analysis
Seung Beom Han et al.
PEDIATRIC DRUGS (2022)
Abrogation of neutrophil inflammatory pathways and potential reduction of neutrophil-related factors in COVID-19 by intravenous immunoglobulin
Jorge Adrian Masso-Silva et al.
FRONTIERS IN IMMUNOLOGY (2022)
Lipidomics links oxidized phosphatidylcholines and coronary arteritis in Kawasaki disease
Yasutaka Nakashima et al.
CARDIOVASCULAR RESEARCH (2021)
Randomized trial of different initial intravenous immunoglobulin regimens in Kawasaki disease
Lan He et al.
PEDIATRICS INTERNATIONAL (2021)
Infliximab versus second intravenous immunoglobulin for treatment of resistant Kawasaki disease in the USA (KIDCARE): a randomised, multicentre comparative effectiveness trial
Jane C. Burns et al.
LANCET CHILD & ADOLESCENT HEALTH (2021)
High Dose Intravenous IgG Therapy Modulates Multiple NK Cell and T Cell Functions in Patients With Immune Dysregulation
Sarah M. McAlpine et al.
FRONTIERS IN IMMUNOLOGY (2021)
Efficacy and safety associated with the infusion speed of intravenous immunoglobulin for the treatment of Kawasaki disease: a randomized controlled trial
Saori Fukui et al.
PEDIATRIC RHEUMATOLOGY (2021)
Endogenous oxidized phospholipids reprogram cellular metabolism and boost hyperinflammation
Marco Di Gioia et al.
NATURE IMMUNOLOGY (2020)
Crucial role of NLRP3 inflammasome in a murine model of Kawasaki disease
Fumiya Anzai et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2020)
Association between P2RY12 Gene Polymorphisms and IVIG Resistance in Kawasaki Patients
Zhouping Wang et al.
CARDIOVASCULAR THERAPEUTICS (2020)
Antibodies and Immunity During Kawasaki Disease
Mark Daniel Hicar
FRONTIERS IN CARDIOVASCULAR MEDICINE (2020)
High-dose versus low-dose intravenous immunoglobulin for treatment of children with Kawasaki disease weighing 25 kg or more
Takanori Suzuki et al.
EUROPEAN JOURNAL OF PEDIATRICS (2020)
Identifying Downregulation of Autophagy Markers in Kawasaki Disease
Fu-Chen Huang et al.
CHILDREN-BASEL (2020)
Effect of Early Intravenous Immunoglobulin Therapy in Kawasaki Disease: A Systematic Review and Meta-Analysis
Fan Yan et al.
FRONTIERS IN PEDIATRICS (2020)
Determination of the Relationship Between Kobayashi, Sano, and Egami Criteria and Prevalence of Intravenous Immunoglobulin Resistance and Coronary Artery Aneurysm in Iranian Children with Kawasaki Disease
Niloufar Shashaani et al.
OPEN ACCESS RHEUMATOLOGY-RESEARCH AND REVIEWS (2020)
Clinical Utility of Highly Purified 10% Liquid Intravenous Immunoglobulin in Kawasaki Disease
Takuya Oda et al.
JOURNAL OF PEDIATRICS (2019)
The time option of IVIG treatment is associated with therapeutic responsiveness and coronary artery abnormalities but not with clinical classification in the acute episode of Kawasaki disease
Sama Samadli et al.
PEDIATRIC RHEUMATOLOGY (2019)
Aetiological Significance of Infectious Stimuli in Kawasaki Disease
Akihiro Nakamura et al.
FRONTIERS IN PEDIATRICS (2019)
HMGB1 gene polymorphism is associated with coronary artery lesions and intravenous immunoglobulin resistance in Kawasaki disease
Jong Gyun Ahn et al.
RHEUMATOLOGY (2019)
The role of echocardiography in Kawasaki disease
Brian W. McCrindle et al.
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (2018)
Predictors of intravenous immunoglobulin-resistant Kawasaki disease in children: a meta-analysis of 4442 cases
Xuan Li et al.
EUROPEAN JOURNAL OF PEDIATRICS (2018)
Kawasaki disease: abnormal initial echocardiogram is associated with resistance to IV Ig and development of coronary artery lesions
Dima Chbeir et al.
PEDIATRIC RHEUMATOLOGY (2018)
Effect of i.v. immunoglobulin in the first 4 days of illness in Kawasaki disease
Yusuke Shiozawa et al.
PEDIATRICS INTERNATIONAL (2018)
Adverse Effects of Immunoglobulin Therapy
Yi Guo et al.
FRONTIERS IN IMMUNOLOGY (2018)
An introduction to immunology and immunopathology
Jean S. Marshall et al.
ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY (2018)
FCN1 (M-ficolin), which directly associates with immunoglobulin G1, is a molecular target of intravenous immunoglobulin therapy for Kawasaki disease
Daisuke Okuzaki et al.
SCIENTIFIC REPORTS (2017)
Predicting Coronary Artery Aneurysms in Kawasaki Disease at a North American Center: An Assessment of Baseline z Scores
Mary Beth F. Son et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2017)
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease A Scientific Statement for Health Professionals From the American Heart Association
Brian W. McCrindle et al.
CIRCULATION (2017)
Kawasaki disease: a matter of innate immunity
T. Hara et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2016)
Kawasaki Disease in India - Lessons Learnt Over the Last 20 Years
Surjit Singh et al.
INDIAN PEDIATRICS (2016)
Markedly elevated CD64 expression on neutrophils and monocytes as a biomarker for diagnosis and therapy assessment in Kawasaki disease
Sho Hokibara et al.
INFLAMMATION RESEARCH (2016)
Variability in Response to Intravenous Immunoglobulin in the Treatment of Kawasaki Disease
Mallory L. Downie et al.
JOURNAL OF PEDIATRICS (2016)
Coronary Artery Aneurysms in Kawasaki Disease: Risk Factors for Progressive Disease and Adverse Cardiac Events in the US Population
Kevin G. Friedman et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2016)
Fine specificities of natural regulatory T cells after IVIG therapy in patients with Kawasaki disease
Jane C. Burns et al.
AUTOIMMUNITY (2015)
Relationship between T-cell HLA-DR expression and intravenous immunoglobulin treatment response in Kawasaki disease
Hiroyuki Wakiguchi et al.
PEDIATRIC RESEARCH (2015)
Inhibition of FcγR-mediated phagocytosis by IVIg is independent of IgG-Fc sialylation and FcγRIIb in human macrophages
Sietse Q. Nagelkerke et al.
BLOOD (2014)
Regulatory T cell microRNA expression changes in children with acute Kawasaki disease
F-F. Ni et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2014)
Kawasaki Disease-Specific Molecules in the Sera Are Linked to Microbe-Associated Molecular Patterns in the Biofilms
Takeshi Kusuda et al.
PLOS ONE (2014)
Immune-monitoring in Kawasaki disease patients treated with infliximab and intravenous immunoglobulin
J. C. Burns et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2013)
DC-SIGN gene promoter variants and IVIG treatment response in Kawasaki disease
Michael A. Portman et al.
PEDIATRIC RHEUMATOLOGY (2013)
Intravenous immunoglobulin suppresses NLRP1 and NLRP3 inflammasome-mediated neuronal death in ischemic stroke
D. Yang-Wei Fann et al.
CELL DEATH & DISEASE (2013)
Role of Activating FcγR Gene Polymorphisms in Kawasaki Disease Susceptibility and Intravenous Immunoglobulin Response
Sadeep Shrestha et al.
CIRCULATION-CARDIOVASCULAR GENETICS (2012)
PAMPs and DAMPs: signal 0s that spur autophagy and immunity
Daolin Tang et al.
IMMUNOLOGICAL REVIEWS (2012)
Functional FCGR2B gene variants influence intravenous immunoglobulin response in patients with Kawasaki disease
Christine Deffert et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2011)
IL-1B Polymorphism in Association With Initial Intravenous Immunoglobulin Treatment Failure in Taiwanese Children With Kawasaki Disease
Ken-Pen Weng et al.
CIRCULATION JOURNAL (2010)
CCR6 is expressed on an IL-10-producing, autoreactive memory T cell population with context-dependent regulatory function
Laura Rivino et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Effectiveness of Medium-Dose Intravenous Immunoglobulin (1 g/kg) in the Treatment of Kawasaki Disease
Joong-Seok Yeo et al.
Korean Circulation Journal (2010)
Prediction of responsiveness or non-responsiveness to treatment of acute Kawasaki disease using 1 gram per kilogram of immunoglobulin - an effective and cost-saving schedule of therapy
Ko Ichihashi et al.
CARDIOLOGY IN THE YOUNG (2009)
Pathogen Recognition and Inflammatory Signaling in Innate Immune Defenses
Trine H. Mogensen
CLINICAL MICROBIOLOGY REVIEWS (2009)
Increased CD11b expression on polymorphonuclear leucocytes and cytokine profiles in patients with Kawasaki disease
T. Kobayashi et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2007)
Prediction of non-responsiveness to standard high-dose gamma-globulin therapy in patients with acute Kawasaki disease before starting initial treatment
Tetsuya Sano et al.
EUROPEAN JOURNAL OF PEDIATRICS (2007)
Prediction of resistance to intravenous immunoglobulin treatment in patients with Kawasaki disease
Kimiyasu Egami et al.
JOURNAL OF PEDIATRICS (2006)
Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease
Tohru Kobayashi et al.
CIRCULATION (2006)
Intravenous immunoglobulin preparations promote apoptosis in hpopolysaccharide-stimulated neutrophils via an oxygen-dependent pathway in vitro
S Takeshita et al.
APMIS (2005)
An immunoglobulin agent (IVIG) inhibits NF-κB activation in cultured endothelial cells of coronary arteries in vitro
T Ichiyama et al.
INFLAMMATION RESEARCH (2004)
CD25+ CD4+ regulatory T cells in patients with Kawasaki disease
K Furuno et al.
JOURNAL OF PEDIATRICS (2004)
Prognostic impact of vascular leakage in acute Kawasaki disease
M Terai et al.
CIRCULATION (2003)
Inhibition of maturation and function of dendritic cells by intravenous immunoglobulin
J Bayry et al.
BLOOD (2003)
Intravenous immunoglobulin therapy induces neutrophil apoptosis in Kawasaki disease
H Tsujimoto et al.
CLINICAL IMMUNOLOGY (2002)
Delayed apoptosis of circulating neutrophils in Kawasaki disease
H Tsujimoto et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2001)
Advances in immunology: Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin.
MD Kazatchkine et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Neutrophils and mononuclear cells express vascular endothelial growth factor in acute Kawasaki disease: Its possible role in progression of coronary artery lesions
Y Hamamichi et al.
PEDIATRIC RESEARCH (2001)
分享论文
